| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
74,525 |
65,054 |
$1.85M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,526 |
5,229 |
$410K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
140,082 |
109,761 |
$404K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,089 |
19,908 |
$403K |
| 80053 |
Comprehensive metabolic panel |
93,561 |
76,890 |
$359K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
4,981 |
1,146 |
$143K |
| 77427 |
|
740 |
318 |
$72K |
| 99215 |
Prolong outpt/office vis |
1,067 |
824 |
$52K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
1,077 |
644 |
$50K |
| 83615 |
|
18,933 |
16,268 |
$31K |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
540 |
88 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,693 |
1,158 |
$30K |
| 96367 |
|
2,582 |
1,557 |
$29K |
| 82728 |
|
10,326 |
10,020 |
$24K |
| 77336 |
|
514 |
227 |
$21K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
179 |
157 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,733 |
3,768 |
$19K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
380 |
222 |
$19K |
| 83550 |
|
10,514 |
10,205 |
$17K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
239 |
232 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,517 |
937 |
$15K |
| 83735 |
|
2,977 |
2,178 |
$14K |
| 83540 |
|
10,495 |
10,183 |
$12K |
| 77334 |
|
120 |
90 |
$12K |
| 99233 |
Prolong inpt eval add15 m |
126 |
39 |
$6K |
| 85055 |
|
711 |
593 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
49 |
46 |
$4K |
| 77290 |
|
13 |
12 |
$4K |
| 77300 |
|
30 |
24 |
$4K |
| 51798 |
|
495 |
473 |
$3K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
27 |
25 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,137 |
984 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
32 |
31 |
$2K |
| 81003 |
|
1,522 |
1,389 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
63 |
14 |
$2K |
| 85027 |
|
403 |
320 |
$2K |
| 86304 |
|
163 |
150 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
40 |
26 |
$1K |
| 85046 |
|
506 |
497 |
$1K |
| 96417 |
|
154 |
101 |
$1K |
| 99205 |
Prolong outpt/office vis |
24 |
24 |
$1K |
| 85007 |
|
403 |
320 |
$986.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,147 |
1,245 |
$921.46 |
| 84100 |
|
227 |
139 |
$891.41 |
| 77263 |
|
13 |
13 |
$820.02 |
| 84460 |
|
300 |
248 |
$706.23 |
| 84450 |
|
300 |
248 |
$693.02 |
| 84075 |
|
300 |
248 |
$690.55 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
41 |
24 |
$680.57 |
| 82247 |
|
300 |
248 |
$669.30 |
| 82607 |
|
105 |
101 |
$584.36 |
| 96523 |
|
86 |
75 |
$562.15 |
| 86300 |
|
162 |
147 |
$476.31 |
| 82040 |
|
170 |
143 |
$396.12 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
259 |
236 |
$392.57 |
| 96402 |
|
12 |
12 |
$349.36 |
| 84155 |
|
203 |
172 |
$318.32 |
| 82378 |
|
68 |
60 |
$308.46 |
| 81001 |
|
157 |
133 |
$241.78 |
| 99223 |
Prolong inpt eval add15 m |
17 |
16 |
$231.36 |
| 82565 |
|
88 |
81 |
$199.52 |
| 82310 |
|
74 |
67 |
$182.91 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$179.34 |
| 82374 |
|
74 |
67 |
$172.66 |
| 84132 |
|
74 |
67 |
$169.17 |
| 82435 |
|
74 |
67 |
$162.94 |
| 84520 |
|
88 |
81 |
$153.99 |
| 36415 |
Collection of venous blood by venipuncture |
97,428 |
73,852 |
$124.66 |
| 82746 |
|
15 |
12 |
$64.34 |
| 84550 |
|
189 |
174 |
$36.70 |
| 85045 |
|
164 |
161 |
$34.97 |
| 90686 |
|
38 |
38 |
$17.93 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
116 |
75 |
$15.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
14 |
12 |
$14.99 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
131 |
128 |
$0.00 |
| 90653 |
|
12 |
12 |
$0.00 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
10,364 |
10,309 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
90 |
90 |
$0.00 |
| G1007 |
Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program |
70 |
68 |
$0.00 |
| 99024 |
|
15 |
12 |
$0.00 |
| 90694 |
|
19 |
19 |
$0.00 |
| 96415 |
|
29 |
12 |
$0.00 |